Search results
FDA issues recall notice for Philips after another respiratory device fails
Medical Device Network via Yahoo Finance· 1 hour agoThe FDA has issued the notice for the company’s Trilogy EVO Continuous Ventilators, warning that...
FDA: Avoid These Dairy Products During the Current Bird Flu Outbreak
Prevention· 7 days agoThe FDA reported which dairy products are safe to eat amid the recent bird flu outbreak. Bird flu...
FDA extends review of Ascendis Pharma's hypoparathyroidism drug By Investing.com
Investing.com· 17 hours agoAscendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company, has received notice from the U.S....
The Forces Weighing Against FDA Bans on Toxic Ingredients
Bloomberg· 2 hours agoGood morning, it’s Fiona in New York. The FDA has missed a deadline for a proposed ban on a...
FDA said it "never" inspected dental lab that made controversial AGGA device
CBS News· 2 days agoThe FDA never inspected Johns Dental Laboratories during more than a decade in which it made the...
US FDA extends review of Ascendis Pharma's hormone disorder therapy
Reuters via AOL· 17 hours agoU.S.-listed shares of the company were down 6.6% in late afternoon trading. The health regulator...
FDA issues ‘most serious type of recall’ involving app-reliant insulin pumps
WPIX New York City, NY via Yahoo News· 1 day agoThe U.S. Food and Drug Administration has issued a recall correction for an Apple iOS app used with...
FDA warns users not to use Cue Health’s at-home Covid-19 tests
Medical Device Network via Yahoo Finance· 1 day agoThe US Food and Drug Administration (FDA) has warned users not to use Cue Health’s at-home Covid-19...
Eisai initiates rolling Biologics License Application to US FDA for Leqembi® (lecanemab-irmb) for...
FOX 23 News Albany· 9 hours agoFood and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: Leqembi) subcutaneous...
New Clozapine Data Suggest FDA Should Ease Restrictions
Medscape· 7 hours agoThe risk for severe neutropenia with clozapine is minimal, suggesting that burdensome FDA-required hematologic monitoring should be relaxed, researchers said.